Dilasha Seth And Sohini Das

Stories by Dilasha Seth And Sohini Das

Made-in-America tax plan may hit India's manufacturing firms

Made-in-America tax plan may hit India's manufacturing firms

Rediff.com   3 May 2021

US proposal to raise the global corporate tax rate to 28% from 21% might face resistance from countries unwilling to give up their edge and compete with America on its terms.

Google tax: American IT and steel lobbies back action against India

Google tax: American IT and steel lobbies back action against India

Rediff.com   3 May 2021

The group has called for a retaliatory tariff action against India, if New Delhi does not roll back the 'unilateral and discriminatory' equalisation levy or Google Tax.

Covid vaccine: Too early to say if booster dose needed

Covid vaccine: Too early to say if booster dose needed

Rediff.com   30 Apr 2021

Initial data has shown immunity triggered by the two mRNA vaccines -- Pfizer-BioNTech and Moderna -- lasts for at least six months

Despite grim outlook, fiscal stimulus unlikely for India Inc this year

Despite grim outlook, fiscal stimulus unlikely for India Inc this year

Rediff.com   29 Apr 2021

They say that a stimulus package may not be necessary because, unlike last year's total lockdown, public transport, including the railways and airlines, is running and the restrictions on movement are localised and, in some cases, are partial rather than total.

Covid vaccine could cost up to Rs 1000 in private market

Covid vaccine could cost up to Rs 1000 in private market

Rediff.com   28 Apr 2021

While the Indian government has been procuring Covid-19 vaccines at low prices so far, manufacturers have to declare the prices of vaccines they would supply to the open market (industries, private hospitals, etc) and state governments before May 1. Sohini Das reports.

A COVID-19 Vaccine Snapshot

A COVID-19 Vaccine Snapshot

Rediff.com   28 Apr 2021

Sputnik V is already approved in India and Sinovac is unlikely to come in as it does not meet the criteria.

Where is the manpower to handle ventilators?

Where is the manpower to handle ventilators?

Rediff.com   25 Apr 2021

The second wave of the pandemic has not only crippled medical infrastructure in terms of hospital beds, but has also led to bottlenecks in invasive ventilators and medical oxygen capacities and supplies.

Demand for Covid-19 tests growing 100 pc week-on-week

Demand for Covid-19 tests growing 100 pc week-on-week

Rediff.com   23 Apr 2021

One challenge for many laboratories in ramping up is the shortage of trained manpower for collecting samples, report Sohini Das, Vinay Umarji and Virendra Singh Rawat.

Shortage of key chemical from US hits Covaxin ramp-up plans

Shortage of key chemical from US hits Covaxin ramp-up plans

Rediff.com   22 Apr 2021

'In case of shortage of other raw material, like filters and bags, one can try to develop another vendor. However, for chemicals as critical as adjuvants, this is not possible'

Serum, Bharat Biotech to get Rs 45 bn for 300 mn vaccines

Serum, Bharat Biotech to get Rs 45 bn for 300 mn vaccines

Rediff.com   20 Apr 2021

This will be an upfront payment for the vaccine doses that these two companies will supply to the government.

Personal income tax rises to Rs 5.7 trillion

Personal income tax rises to Rs 5.7 trillion

Rediff.com   20 Apr 2021

'Personal income tax collections have been high on account of impressive advance tax mop-up.'

States want GST exemption on Remdesivir, others

States want GST exemption on Remdesivir, others

Rediff.com   19 Apr 2021

Other decisions piled up include rationalisation of GST rate slabs, correction of inverted duty on certain items and inclusion of petroleum products.

COVID-19 vaccine: Why Poonawalla wrote to Biden

COVID-19 vaccine: Why Poonawalla wrote to Biden

Rediff.com   17 Apr 2021

'The US has invoked the Defence Act and banned export of raw materials.' 'This is as good as banning vaccines.'

100 million Covaxin vaccines by Sept

100 million Covaxin vaccines by Sept

Rediff.com   17 Apr 2021

The production of Covaxin will increase from the current 10 million doses per month to 60 million-70 million by July-August.

Second Covid wave is 1.7x times faster than first wave, shows data

Second Covid wave is 1.7x times faster than first wave, shows data

Rediff.com   15 Apr 2021

It has taken 51 days to reach a daily caseload of 84,000 from 11,000, as against 85 days taken in the first wave, report Abhishek Waghmare and Sohini Das.

'We will be prioritising vaccine only for India'

'We will be prioritising vaccine only for India'

Rediff.com   14 Apr 2021

'I don't think anybody would want to be in my position today where every head of State has to be explained that I am prioritising my country because there is a surge in cases.'

Serum, Bharat Bio seek govt funds to boost vaccine output

Serum, Bharat Bio seek govt funds to boost vaccine output

Rediff.com   5 Apr 2021

Both manufacturers have sought funds in excess of Rs 150 crore under the department of biotechnology's Mission Covid Suraksha scheme. Announced last November, the scheme has an outlay of Rs 900 crore to help develop Covid vaccines, from the clinical development stage to setting up production sites.

Expert panel seeks more data on Sputnik V Covid vaccine

Expert panel seeks more data on Sputnik V Covid vaccine

Rediff.com   2 Apr 2021

'No approval was given to Sputnik V on Thursday. Some queries have been asked on safety, efficacy, and logistics, which the firm will have answers to at the next meeting'

Govt to infuse Rs 14,500 crore in 4 banks, issue recapitalisation bonds

Govt to infuse Rs 14,500 crore in 4 banks, issue recapitalisation bonds

Rediff.com   1 Apr 2021

Zero-coupon bonds don't give out interest but are issued at a deep discount to the face value, making it difficult to ascertain the net present value.

Sputnik V vaccine may be added to India's Covid armoury soon

Sputnik V vaccine may be added to India's Covid armoury soon

Rediff.com   30 Mar 2021

'We expect to get the approval in the next few weeks,' says Deepak Sapra, CEO, API and pharmaceutical services, Dr Reddy's Laboratories (DRL).